Eli Lilly and Company (Akouos)

New Capabilities

Developing AK-OTOF gene therapy through acquired subsidiary

Children born profoundly deaf can now hear their parents' voices. A single injection of gene therapy into the inner ear has restored hearing in dozens of patients with genetic deafness, moving some forms of lifelong hearing loss from permanent disability into the treatable category. The effect is rapid—most patients recover hearing within weeks—and sustained over at least two years of follow-up.

Updated Jan 9